Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1992 Aug;89(2):321–324. doi: 10.1111/j.1365-2249.1992.tb06953.x

Decreased polymorphonuclear leucocyte chemotactic response to leukotriene B4 in cystic fibrosis.

R H Lawrence 1, T C Sorrelli 1
PMCID: PMC1554439  PMID: 1322257

Abstract

Evidence that leukotriene B4 (LTB4) is a significant inflammatory mediator in chronic pseudomonal respiratory disease was sought in adolescents and young adults with cystic fibrosis. Specific chemotaxis of peripheral blood polymorphonuclear leucocytes (PMN) was used as an indirect measure of remote in vivo exposure to LTB4. PMN from 17 patients showed a significant decrease in chemotaxis to 10(-7)-10(-9) M LTB4, but normal responses to 10(-8) M n-formyl-methionyl-leucyl-phenylalanine and 4 mg/ml casein, when compared with 17 healthy age- and sex-matched controls. This result is consistent with chronic production of LTB4, and specific deactivation of circulating PMN receptors for LTB4 in patients with cystic fibrosis. Pharmacologic inhibition of LTB4 production in vivo may help elucidate its role in the pathogenesis of lung damage in cystic fibrosis.

Full text

PDF
321

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bergmann U., Scheffer J., Köller M., Schönfeld W., Erbs G., Müller F. E., König W. Induction of inflammatory mediators (histamine and leukotrienes) from rat peritoneal mast cells and human granulocytes by Pseudomonas aeruginosa strains from burn patients. Infect Immun. 1989 Jul;57(7):2187–2195. doi: 10.1128/iai.57.7.2187-2195.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Böyum A. Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest Suppl. 1968;97:77–89. [PubMed] [Google Scholar]
  3. Church J. A., Keens T. G., Wang C. I. Neutrophil and monocyte chemotaxis in acutely infected patients with cystic fibrosis. Ann Allergy. 1980 Oct;45(4):217–219. [PubMed] [Google Scholar]
  4. Cromwell O., Walport M. J., Morris H. R., Taylor G. W., Hodson M. E., Batten J., Kay A. B. Identification of leukotrienes D and B in sputum from cystic fibrosis patients. Lancet. 1981 Jul 25;2(8239):164–165. doi: 10.1016/s0140-6736(81)90353-6. [DOI] [PubMed] [Google Scholar]
  5. Davis J. M., Meyer J. D., Barie P. S., Yurt R. W., Duhaney R., Dineen P., Shires G. T. Elevated production of neutrophil leukotriene B4 precedes pulmonary failure in critically ill surgical patients. Surg Gynecol Obstet. 1990 Jun;170(6):495–500. [PubMed] [Google Scholar]
  6. Davis P. B., di Sant'Agnese P. A. Diagnosis and treatment of cystic fibrosis. An update. Chest. 1984 Jun;85(6):802–809. doi: 10.1016/s0012-3692(16)62421-2. [DOI] [PubMed] [Google Scholar]
  7. Elmgreen J., Hansen T. M. Subnormal sensitivity of neutrophils to complement split product C5a in rheumatoid arthritis: relation to complement catabolism and disease extent. Ann Rheum Dis. 1985 Aug;44(8):514–518. doi: 10.1136/ard.44.8.514. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Fick R. B., Jr, Robbins R. A., Squier S. U., Schoderbek W. E., Russ W. D. Complement activation in cystic fibrosis respiratory fluids: in vivo and in vitro generation of C5a and chemotactic activity. Pediatr Res. 1986 Dec;20(12):1258–1268. doi: 10.1203/00006450-198612000-00014. [DOI] [PubMed] [Google Scholar]
  9. Goldman D. W., Goetzl E. J. Heterogeneity of human polymorphonuclear leukocyte receptors for leukotriene B4. Identification of a subset of high affinity receptors that transduce the chemotactic response. J Exp Med. 1984 Apr 1;159(4):1027–1041. doi: 10.1084/jem.159.4.1027. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hill H. R., Warwick W. J., Dettloff J., Quie P. G. Neutrophil granulocyte function in patients with pulmonary infection. J Pediatr. 1974 Jan;84(1):55–58. doi: 10.1016/s0022-3476(74)80553-6. [DOI] [PubMed] [Google Scholar]
  11. Hopkins H., Stull T., Von Essen S. G., Robbins R. A., Rennard S. I. Neutrophil chemotactic factors in bacterial pneumonia. Chest. 1989 May;95(5):1021–1027. doi: 10.1378/chest.95.5.1021. [DOI] [PubMed] [Google Scholar]
  12. Høiby N., Döring G., Schiøtz P. O. The role of immune complexes in the pathogenesis of bacterial infections. Annu Rev Microbiol. 1986;40:29–53. doi: 10.1146/annurev.mi.40.100186.000333. [DOI] [PubMed] [Google Scholar]
  13. Kemp A., Roberts-Thomson P., Brown S. Inhibition of human neutrophil migration by aggregated gammaglobulin. Clin Exp Immunol. 1979 May;36(2):334–341. [PMC free article] [PubMed] [Google Scholar]
  14. Kharazmi A., Schiøtz P. O., Høiby N., Baek L., Döring G. Demonstration of neutrophil chemotactic activity in the sputum of cystic fibrosis patients with Pseudomonas aeruginosa infection. Eur J Clin Invest. 1986 Apr;16(2):143–148. doi: 10.1111/j.1365-2362.1986.tb01321.x. [DOI] [PubMed] [Google Scholar]
  15. Klickstein L. B., Shapleigh C., Goetzl E. J. Lipoxygenation of arachidonic acid as a source of polymorphonuclear leukocyte chemotactic factors in synovial fluid and tissue in rheumatoid arthritis and spondyloarthritis. J Clin Invest. 1980 Nov;66(5):1166–1170. doi: 10.1172/JCI109947. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Lee T. H., Hoover R. L., Williams J. D., Sperling R. I., Ravalese J., 3rd, Spur B. W., Robinson D. R., Corey E. J., Lewis R. A., Austen K. F. Effect of dietary enrichment with eicosapentaenoic and docosahexaenoic acids on in vitro neutrophil and monocyte leukotriene generation and neutrophil function. N Engl J Med. 1985 May 9;312(19):1217–1224. doi: 10.1056/NEJM198505093121903. [DOI] [PubMed] [Google Scholar]
  17. Marcus A. J., Safier L. B., Ullman H. L., Broekman M. J., Islam N., Oglesby T. D., Gorman R. R. 12S,20-dihydroxyicosatetraenoic acid: a new icosanoid synthesized by neutrophils from 12S-hydroxyicosatetraenoic acid produced by thrombin- or collagen-stimulated platelets. Proc Natl Acad Sci U S A. 1984 Feb;81(3):903–907. doi: 10.1073/pnas.81.3.903. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Martin T. R., Pistorese B. P., Chi E. Y., Goodman R. B., Matthay M. A. Effects of leukotriene B4 in the human lung. Recruitment of neutrophils into the alveolar spaces without a change in protein permeability. J Clin Invest. 1989 Nov;84(5):1609–1619. doi: 10.1172/JCI114338. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Martin T. R., Raugi G., Merritt T. L., Henderson W. R., Jr Relative contribution of leukotriene B4 to the neutrophil chemotactic activity produced by the resident human alveolar macrophage. J Clin Invest. 1987 Oct;80(4):1114–1124. doi: 10.1172/JCI113168. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Nielsen O. H., Elmgreen J. Activation of neutrophil chemotaxis by leukotriene B4 and 5-hydroxyeicosatetraenoic acid in chronic inflammatory bowel disease. Scand J Clin Lab Invest. 1987 Oct;47(6):605–611. doi: 10.1080/00365518709168476. [DOI] [PubMed] [Google Scholar]
  21. O'Driscoll B. R., Cromwell O., Kay A. B. Sputum leukotrienes in obstructive airways diseases. Clin Exp Immunol. 1984 Feb;55(2):397–404. [PMC free article] [PubMed] [Google Scholar]
  22. Penketh A. R., Wise A., Mearns M. B., Hodson M. E., Batten J. C. Cystic fibrosis in adolescents and adults. Thorax. 1987 Jul;42(7):526–532. doi: 10.1136/thx.42.7.526. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Reilly I. A., Knapp H. R., Fitzgerald G. A. Leukotriene B4 synthesis and neutrophil chemotaxis in chronic granulocytic leukaemia. J Clin Pathol. 1988 Nov;41(11):1163–1167. doi: 10.1136/jcp.41.11.1163. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Sampson A. P., Spencer D. A., Green C. P., Piper P. J., Price J. F. Leukotrienes in the sputum and urine of cystic fibrosis children. Br J Clin Pharmacol. 1990 Dec;30(6):861–869. doi: 10.1111/j.1365-2125.1990.tb05452.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Sperling R. I., Weinblatt M., Robin J. L., Ravalese J., 3rd, Hoover R. L., House F., Coblyn J. S., Fraser P. A., Spur B. W., Robinson D. R. Effects of dietary supplementation with marine fish oil on leukocyte lipid mediator generation and function in rheumatoid arthritis. Arthritis Rheum. 1987 Sep;30(9):988–997. doi: 10.1002/art.1780300905. [DOI] [PubMed] [Google Scholar]
  26. Suter S., Schaad U. B., Roux L., Nydegger U. E., Waldvogel F. A. Granulocyte neutral proteases and Pseudomonas elastase as possible causes of airway damage in patients with cystic fibrosis. J Infect Dis. 1984 Apr;149(4):523–531. doi: 10.1093/infdis/149.4.523. [DOI] [PubMed] [Google Scholar]
  27. Zakrzewski J. T., Barnes N. C., Piper P. J., Costello J. F. Detection of sputum eicosanoids in cystic fibrosis and in normal saliva by bioassay and radioimmunoassay. Br J Clin Pharmacol. 1987 Jan;23(1):19–27. doi: 10.1111/j.1365-2125.1987.tb03004.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Zielinski C. C., Götz M., Ahmad R., Eibl M. M. Defective leukocyte locomotion in cystic fibrosis. N Engl J Med. 1982 Feb 25;306(8):486–487. [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES